713124383	713124383	CD	B-NP	O
|	|	NN	I-NP	O
LTH	LTH	NN	I-NP	O
|	|	NN	I-NP	O
39256367	39256367	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7537687	7537687	CD	B-NP	O
|	|	CC	I-NP	O
1/1/2004	1/1/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
calcaneous	calcaneous	JJ	B-NP	O
fracture	fracture	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/1/2004	1/1/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/5/2004	8/5/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
STRAUSBERG	STRAUSBERG	NNP	B-NP	O
,	,	,	O	O
EMILIO	EMILIO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
547-71-30-4	547-71-30-4	CD	I-NP	O
Car	Car	NNP	I-NP	O
Rock	Rock	NNP	I-NP	O
E	E	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
4/11/04	4/11/04	CD	B-NP	O
AT	AT	NN	I-NP	O
07	07	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BLEICHNER	BLEICHNER	NNP	B-NP	O
,	,	,	O	O
DERICK	DERICK	NNP	B-NP	O
STUART	STUART	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/28/04	5/28/04	CD	B-NP	O
by	by	IN	B-PP	O
LOESER	LOESER	NNP	B-NP	O
,	,	,	O	O
VALENTIN	VALENTIN	NNP	B-NP	O
GUADALUPE	GUADALUPE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
heart	heart	NN	B-NP	O
VITAMIN	VITAMIN	NN	I-NP	O
B12	B12	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CYANOCOBALAMIN	CYANOCOBALAMIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.25	0.25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	JJR	B-NP	O
105	105	CD	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
OXYCODONE	OXYCODONE	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
May	May	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/28/04	5/28/04	CD	B-NP	O
by	by	IN	B-PP	O
GLUSZEK	GLUSZEK	NNP	B-NP	O
,	,	,	O	O
MAX	MAX	NNP	B-NP	O
JORDON	JORDON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ECASA	ECASA	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
32475525	32475525	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
heart	heart	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/28/04	5/28/04	CD	B-NP	O
by	by	IN	B-PP	O
TUMMINIA	TUMMINIA	NNP	B-NP	O
,	,	,	O	O
KING	KING	NNP	B-NP	O
G	G	NNP	I-NP	O
VALENTINE	VALENTINE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LIPITOR	LIPITOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
53215289	53215289	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
40mg	40mg	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

300	300	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/28/04	5/28/04	CD	B-NP	O
by	by	IN	B-PP	O
TRAUTMAN	TRAUTMAN	NN	B-NP	O
,	,	,	O	O
BRENTON	BRENTON	NNP	B-NP	O
STAN	STAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
48956178	48956178	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/28/04	5/28/04	CD	B-NP	O
by	by	IN	B-PP	O
RYKERT	RYKERT	NNP	B-NP	O
,	,	,	O	O
DARRIN	DARRIN	NNP	B-NP	O
Q	Q	NNP	I-NP	O
PORFIRIO	PORFIRIO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TIAZAC	TIAZAC	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
15645215	15645215	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/28/04	5/28/04	CD	B-NP	O
by	by	IN	B-PP	O
WEIGHT	WEIGHT	NNP	B-NP	O
,	,	,	O	O
YONG	YONG	NNP	B-NP	O
E	E	NNP	I-NP	O
ANTOINE	ANTOINE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DILTIAZEM	DILTIAZEM	NN	B-NP	O
SUSTAINED	SUSTAINED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
53263961	53263961	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
emd	emd	NN	I-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
ACCUPRIL	ACCUPRIL	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
QUINAPRIL	QUINAPRIL	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	JJR	B-NP	O
105	105	CD	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
TIAZAC	TIAZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
DILTIAZEM	DILTIAZEM	NN	I-NP	O
EXTENDED	EXTENDED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
240	240	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
May	May	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/28/04	5/28/04	CD	B-NP	O
by	by	IN	B-PP	O
PLACK	PLACK	NNP	B-NP	O
,	,	,	O	O
MILES	MILES	NNP	B-NP	O
ALONSO	ALONSO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
DILTIAZEM	DILTIAZEM	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/28/04	5/28/04	CD	B-NP	O
by	by	IN	B-PP	O
ALLGIER	ALLGIER	NNP	B-NP	O
,	,	,	O	O
JOEL	JOEL	NNP	B-NP	O
JUNIOR	JUNIOR	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
40mg	40mg	NN	I-NP	O
NIASPAN	NIASPAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NICOTINIC	NICOTINIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
SUSTAINED	SUSTAINED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
GM	GM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/28/04	5/28/04	CD	B-NP	O
by	by	IN	B-PP	O
RATTEE	RATTEE	NN	B-NP	O
,	,	,	O	O
LEWIS	LEWIS	NNP	B-NP	O
IRA	IRA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LIPITOR	LIPITOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
53215289	53215289	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
40mg	40mg	NN	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
66	66	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	B-protein
LISPRO	LISPRO	NNP	I-NP	I-protein
MIX	MIX	NNP	I-NP	I-protein
75/25	75/25	CD	I-NP	I-protein
74	74	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
LISPRO	LISPRO	NNP	I-NP	O
MIX	MIX	NNP	I-NP	O
75/25	75/25	CD	I-NP	O
54	54	CD	I-NP	O
UNITS	UNITS	NNS	I-NP	O
SC	SC	NN	I-NP	O
QPM	QPM	NN	I-NP	O
GLUCOMETER	GLUCOMETER	NN	I-NP	O
1	1	CD	I-NP	O
EA	EA	NN	I-NP	O
SC	SC	NNP	I-NP	O
x1	x1	NN	I-NP	O
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	O
QUICK	QUICK	NNP	I-NP	O
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
TAB	TAB	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Upset	Upset	NNP	I-NP	O
Stomach	Stomach	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Partial	Partial	JJ	B-NP	O
weight-bearing	weight-bearing	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
Lt	Lt	NN	B-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

Use	Use	NN	B-NP	O
air	air	NN	I-NP	O
cast	cast	NN	I-NP	O
.	.	.	O	O

FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Orthopedics	Orthopedic	NNS	B-NP	O
,	,	,	O	O
first	first	JJ	B-NP	O
week	week	NN	I-NP	O
February	February	NNP	B-NP	O
851447-2161	851447-2161	CD	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
magouyrk	magouyrk	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
June	June	NNP	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
2/15/04	2/15/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
30	30	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Morrin	Morrin	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
'	'	''	O	O
PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
calcaneous	calcaneous	JJ	B-NP	O
fracture	fracture	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CT	CT	NN	I-NP	O
foot	foot	NN	I-NP	O
,	,	,	O	O
Plain	Plain	NN	B-NP	O
film	film	NN	I-NP	O
foot	foot	NN	I-NP	O
3views	3view	NNS	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Schmider	Schmider	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64yo	64yo	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
T2DM	T2DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
afib	afib	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
several	several	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
after	after	IN	B-PP	O
becoming	become	VBG	B-VP	O
dizzy	dizzy	JJ	B-ADJP	O
while	while	IN	B-SBAR	O
shovelling	shovel	VBG	B-VP	O
snow	snow	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pateint	pateint	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
taken	take	VBN	I-VP	O
his	his	PRP$	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
medications	medication	NNS	I-NP	O
this	this	DT	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
shovelling	shovel	VBG	I-VP	O
snow	snow	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
dizziness/lightheadedness	dizziness/lightheadedness	NN	B-NP	O
and	and	CC	O	O
fell	fall	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
kness	kness	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
head	head	NN	I-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

Did	Do	VBD	B-VP	O
expereince	expereince	IN	B-PP	O
generalized	generalize	VBN	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
slurred	slurred	JJ	I-NP	O
speech	speech	NN	I-NP	O
,	,	,	O	O
focal	focal	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
incontinence	incontinence	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
palpitation	palpitation	NN	I-NP	B-protein
s.	s.	NN	I-NP	I-protein
EMS-HR	EMS-HR	NN	I-NP	I-protein
140s-160s	140s-160	NNS	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
190/90	190/90	CD	I-NP	I-DNA
,	,	,	O	O
in	in	IN	B-PP	O
ED	ED	VBN	B-NP	O
rate	rate	NN	I-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
metoprolol	metoprolol	NN	I-NP	O
and	and	CC	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
.	.	.	O	O

HR	HR	NN	B-NP	O
100s	100	NNS	I-NP	O
,	,	,	O	O
SBP	SBP	NN	B-NP	B-protein
100s	100	NNS	I-NP	I-protein
.	.	.	O	O

Exam	Exam	NNP	B-NP	O
JVP	JVP	NNP	I-NP	O
8-10	8-10	CD	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
CTA	CTA	NN	I-NP	O
,	,	,	O	O
CV	CV	NN	B-NP	O
irreg	irreg	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
MRG	MRG	NNP	I-NP	O
,	,	,	I-NP	O
Abd	Abd	NNP	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
LE	LE	NN	I-NP	O
trace	trace	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
absent	absent	JJ	I-NP	O
left	left	JJ	I-NP	O
DP	DP	NN	I-NP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	B-protein
creat	creat	VBP	B-VP	O
2.1	2.1	CD	B-NP	O
-LRB-	-LRB-	JJ	I-NP	O
base	base	NN	I-NP	O
~	~	NN	I-NP	O
1.7	1.7	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
dig	dig	NN	B-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
trop	trop	NN	B-NP	O
0.1	0.1	CD	I-NP	O
,	,	,	O	O
ckmb	ckmb	NN	B-NP	B-protein
10.5	10.5	CD	I-NP	I-protein
,	,	,	O	O
ck	ck	NN	B-NP	O
383	383	CD	I-NP	O
.	.	.	O	O

****	****	SYM	O	B-protein
HOSP	HOSP	NN	B-NP	I-protein
COURSE	COURSE	NN	I-NP	I-protein
***	***	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

CV	CV	NNP	B-NP	O
Isch	Isch	NNP	I-NP	O
:	:	:	O	O
Most	Most	JJS	B-NP	O
c/w	c/w	NN	I-NP	O
demand	demand	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Gave	Gave	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
lipitor/niacin	lipitor/niacin	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
incr	incr	NN	I-NP	O
lipitor	lipitor	NN	I-NP	O
40	40	CD	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
80	80	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
3.3	3.3	CD	I-NP	O
so	so	IN	B-SBAR	O
no	no	DT	B-NP	O
heparin	heparin	NN	I-NP	O
.	.	.	O	O

Enzymes	Enzyme	NNS	B-NP	B-protein
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
from	from	IN	B-PP	O
0/1	0/1	CD	B-NP	O
-	-	HYPH	B-ADJP	O
>	>	SYM	B-NP	O
0.24	0.24	CD	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
0.23	0.23	CD	B-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
Mildly	Mildly	RB	B-NP	O
incr	incr	NN	I-NP	O
JVP	JVP	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
;	;	:	O	O
continue	continue	VB	B-VP	O
lasix	lasix	CD	B-NP	O
,	,	,	O	O
60	60	CD	B-NP	O
bid	bid	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
was	be	VBD	B-VP	O
40po	40po	JJ	B-NP	O
TID	TID	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Telemetry	Telemetry	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
insulin	insulin	NN	I-NP	O
.	.	.	O	O

Provided	Provide	VBN	B-NP	O
diabetes	diabetes	NN	I-NP	O
education	education	NN	I-NP	O
.	.	.	O	O

Provided	Provide	VBN	B-NP	O
glucometer	glucometer	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
CRI	CRI	NN	B-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
susp	susp	NN	I-NP	O
PE	PE	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
INR	INR	NN	B-NP	O
3.3	3.3	CD	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
asym	asym	NN	I-NP	B-protein
LE	LE	NN	I-NP	I-protein
swelling	swell	VBG	B-VP	I-protein
5	5	CD	B-NP	I-protein
.	.	.	O	O

MSK	MSK	NN	B-NP	B-protein
:	:	:	O	O
sustained	sustained	JJ	B-NP	O
fall	fall	NN	I-NP	O
to	to	TO	B-VP	O
Lt	Lt	VB	I-VP	O
heel	heel	NN	B-NP	O
during	during	IN	B-PP	O
presyncope	presyncope	NN	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-NP	O
p	p	NN	I-NP	O
ain	ain	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
difficulty	difficulty	NN	I-NP	O
with	with	IN	B-PP	O
weight	weight	NN	B-NP	O
bearting	bearting	NN	I-NP	O
.	.	.	O	O

Tenderness	Tenderness	NN	B-NP	O
over	over	IN	B-PP	O
tallus	tallus	NN	B-NP	O
.	.	.	O	O

Plain	Plain	NN	B-NP	O
films	film	NNS	I-NP	O
showed	show	VBD	B-VP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
cal	cal	JJ	I-NP	O
caneous	caneous	JJ	I-NP	O
and	and	CC	I-NP	O
tallus	tallus	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

Discussed	Discuss	VBN	B-VP	O
with	with	IN	B-PP	O
orthopedics	orthopedic	NNS	B-NP	O
.	.	.	O	O

Provided	Provide	VBN	B-NP	O
hard	hard	JJ	I-NP	O
boot	boot	NN	I-NP	O
.	.	.	O	O

told	tell	VBN	B-VP	O
to	to	TO	B-VP	O
not	not	RB	I-VP	O
bear	bear	VB	I-VP	O
full	full	JJ	B-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
left	left	JJ	B-NP	O
foot	foot	NN	I-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
performed	perform	VBN	B-VP	O
with	with	IN	B-PP	O
reconstitutions	reconstitution	NNS	B-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
avulsion	avulsion	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RB	B-ADVP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
from	from	IN	B-PP	O
discharge	discharge	NN	B-NP	O
with	with	IN	B-PP	O
orthopedics	orthopedics	JJ	B-NP	O
ambulatory	ambulatory	JJ	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

Code	Code	NNP	B-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	JJ	B-NP	O
orthopedics	orthopedic	NNS	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
your	your	PRP$	B-NP	O
foot	foot	NN	I-NP	O
fracture	fracture	NN	I-NP	O
6153268726	6153268726	CD	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
taught	teach	VBN	I-VP	O
here	here	RB	B-ADVP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
yoru	yoru	NN	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
QUILLER	QUILLER	NNP	B-NP	O
,	,	,	O	O
ELBERT	ELBERT	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.PHIL	M.PHIL	NNP	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	HYPH	B-NP	O
UH184	UH184	NN	I-NP	B-cell_line
-RRB-	-RRB-	HYPH	B-NP	O
4/11/04	4/11/04	CD	I-NP	O
@	@	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
27	27	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

